+Compare
GSK
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
68.47B

GSK Price Prediction, GSK plc AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
GSK Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Nov 29, 2022

Momentum Indicator for GSK turns positive, indicating new upward trend

GSK saw its Momentum Indicator move above the 0 level on November 17, 2022. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 40 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 48%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GSK just turned positive on November 18, 2022. Looking at past instances where GSK's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for GSK crossed bullishly above the 50-day moving average on October 26, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GSK advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 251 cases where GSK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GSK moved out of overbought territory on November 03, 2022. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GSK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GSK broke above its upper Bollinger Band on November 22, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.223) is normal, around the industry mean (5.315). P/E Ratio (12.804) is within average values for comparable stocks, (33.270). Projected Growth (PEG Ratio) (1.076) is also within normal values, averaging (4.319). GSK's Dividend Yield (0.056) is considerably higher than the industry average of (0.026). P/S Ratio (1.485) is also within normal values, averaging (4.128).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GSK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock slightly worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

GSK is expected to report earnings to rise 41.72% to 66 cents per share on July 27

GSK plc GSK Stock Earnings Reports
Q2'22
Est.
$0.67
Q3'22
Missed
by $0.49
Q1'22
Beat
by $0.04
Q4'21
Beat
by $0.04
Q3'21
Beat
by $0.22
The last earnings report on November 02 showed earnings per share of 46 cents, missing the estimate of 95 cents. With 1.86M shares outstanding, the current market capitalization sits at 68.47B.
AI
A.I.Advisor
published Dividends

GSK is expected to pay dividends on January 12, 2023

GSK plc GSK Stock Dividends
A dividend of $0.32 per share will be paid with a record date of January 12, 2023, and an ex-dividend date of November 17, 2022. The last dividend of $0.34 was paid on July 01. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.79B. The market cap for tickers in the group ranges from 226K to 463.63B. JNJ holds the highest valuation in this group at 463.63B. The lowest valued company is NEWG at 226K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 3%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -2%. CRXTQ experienced the highest price growth at 156%, while BIIB experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -62%. For the same stocks of the Industry, the average monthly volume growth was -77% and the average quarterly volume growth was -71%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 26
P/E Growth Rating: 47
Price Growth Rating: 45
SMR Rating: 44
Profit Risk Rating: 61
Seasonality Score: -11 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and other pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
980 Great West Road
Phone
+44 2080475000
Employees
90096
Web
https://www.gsk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFRM12.810.23
+1.83%
Affirm Holdings
PCT6.350.10
+1.60%
PureCycle Technologies
PH294.14-0.93
-0.32%
Parker-Hannifin Corp
OPTT0.62-0.01
-1.59%
Ocean Power Technologies
ARBE3.95-0.16
-3.89%
Arbe Robotics Ltd

GSK and

Correlation & Price change

A.I.dvisor tells us that GSK and SNY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GSK and SNY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
+1.81%
SNY - GSK
29%
Poorly correlated
+0.72%
NVS - GSK
25%
Poorly correlated
-0.36%
GILD - GSK
21%
Poorly correlated
+0.65%
PFE - GSK
16%
Poorly correlated
-0.26%
MRK - GSK
14%
Poorly correlated
+0.35%
More